- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
0 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$3.5b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$4.52
7D
20.9%
1Y
242.4%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.64
7D
-1.6%
1Y
45.6%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.85
7D
6.8%
1Y
20.9%
Trulieve Cannabis
Market Cap: CA$2.0b
Operates as a cannabis retailer in the United States.
TRUL
CA$11.85
7D
35.9%
1Y
91.4%